Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Xenova (XNVA)

No earlier versions found for this Subject.

Return to Xenova (XNVA)

Doesn't have a thread, and deserves one.
With the market in general, and biotechs in particlar the grip of "necrotising pessimism", it seems like a good time to set one up.

As the PR says -
Xenova Group plc is an emerging bio-pharmaceutical company focusing on the therapeutic areas of cancer and immune system disorders. Xenova's directors believe that it has a strong and well balanced portfolio of product candidates in development, with 8 products in clinical trials and a further 8 in preclinical development. The Group has a strong track record in the discovery and development of novel drug candidates and has established partnerships with major pharmaceutical companies including Lilly, Pfizer, Celltech, Genentech, QLT and Millennium Pharmaceuticals...